Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

9807	Companies
196783	Keywords
127785	Articles
104617	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 07/03/2025 at 07:00, 7 months 2 days ago

Biophytis Propulse l’Innovation dans l’Obésité, la Santé Musculaire et la Longévité à la BIO International 2025
BiophyHs SA présente ses avancées dans l'obésité, la sarcopénie et la longévité à la BIO Interna(onal 2025, soulignant ses thérapies innovantes et partenariats stratégiques pour le développement mondial

Longévité Sarcopénie Obésité BiophyHs SA BIO InternaHonal 2025
PRESS RELEASE

published on 07/03/2025 at 06:59, 7 months 2 days ago

Biophytis Propulse l’Innovation dans l’Obésité, la Santé Musculaire et la Longévité à la BIO International 2025
BiophyHs annonce son succès à la BIO International Convention 2025, présentant des avancées en obésité, sarcopénie et longévité, avec des partenariats stratégiques post-conférence

Longévité Sarcopénie Obésité BIO International Convention 2025 BiophyHs
BRIEF

published on 06/30/2025 at 22:35, 7 months 4 days ago

Biophytis reporte la publication de ses comptes annuels

Biophytis Biotechnologie Comptes Annuels Recherche Clinique Publication Retardée
BRIEF

published on 06/30/2025 at 22:35, 7 months 4 days ago

Biophytis Delays Publication of 2024 Annual Financial Statements

Biophytis Biotechnology Drug Development Annual Accounts Financial Delay
REGULATED PRESS RELEASE

published on 06/30/2025 at 22:30, 7 months 4 days ago

Information on the Annual Financial Statements
Biophytis delays publishing of 2024 annual accounts, aiming for release by July 7. The company focuses on treatments for age-related diseases

Financial Statements Biophytis Age-related Diseases 2024 Annual Accounts Clinical-stage Biotechnology Company
REGULATED PRESS RELEASE

published on 06/30/2025 at 22:30, 7 months 4 days ago

Information sur les comptes annuels
Biophytis SA informe qu'elle n'est pas en mesure de publier ses comptes annuels 2024 à la date prévue mais les publiera au plus tard le 07 juillet 2025

Biophytis Développement Biotechnologie Comptes Annuels Maladies Liées À L'âge
PRESS RELEASE

published on 06/30/2025 at 22:29, 7 months 4 days ago

Information sur les comptes annuels
Biophytis SA informe qu'elle reporte la publication de ses comptes annuels 2024 mais s'engage pour une publication rapide. Analyse des risques liés aux déclarations prospectives incluses

Comptes Annuels Déclarations Prospectives Publication Biophytis SA Risques
PRESS RELEASE

published on 06/30/2025 at 22:29, 7 months 4 days ago

Information on the Annual Financial Statements
Biophytis SA delays publication of 2024 annual accounts, aiming to release by July 7. The clinical-stage biotech company focuses on age-related disease treatments

Biotechnology Company Clinical-stage Biophytis SA Age-related Diseases 2024 Annual Accounts
BRIEF

published on 06/19/2025 at 23:05, 7 months 15 days ago

Biophytis suspend temporairement la cotation de son action

Biophytis Euronext Growth Rapport Financier Suspension Cotation Certification Comptes
BRIEF

published on 06/19/2025 at 23:05, 7 months 15 days ago

Biophytis Temporarily Suspends Share Trading

Biophytis Regulatory Compliance Financial Report Euronext Growth Share Suspension

Accesswire

Published on 02/05/2026 at 13:30, 34 minutes ago

Nextech3D.ai to Report Q3 2025 Earnings After Market Close on February 18, 2026
Published on 02/05/2026 at 13:30, 34 minutes ago

ESGold Expands Montauban Land Position Following 3D Geological Model Identifying Potential District-Scale Mineralized Corridor
Published on 02/05/2026 at 13:20, 44 minutes ago

Guanajuato Silver Sees Significant Growth in Resources at Valenciana
Published on 02/05/2026 at 13:15, 49 minutes ago

Avino Appoints Linda Broughton to The Board of Directors
Published on 02/05/2026 at 13:00, 1 hour 4 minutes ago

urban-gro to Implement 1-for-25 Reverse Stock Split

View all ACCESSWIRE

EQS Group

Published on 02/05/2026 at 13:30, 33 minutes ago

Ascory Bank ends its year of transformation in 2025 with positive results and starts 2026 with a new strategy and a new name
Published on 02/05/2026 at 13:04, 1 hour ago

EQS-Adhoc: Ascory Bank AG raises earnings forecast for financial year 2025
Published on 02/05/2026 at 12:48, 1 hour 15 minutes ago

Turkiye Garanti Bankasi A.S.: Announcement regarding forward looking statements on the expectations for the year 2026
Published on 02/05/2026 at 12:45, 1 hour 19 minutes ago

R.E.A. Holdings plc: Notification of Major Holdings
Published on 02/05/2026 at 11:47, 2 hours 17 minutes ago

Worthington Steel Announces Start of Acceptance Period for All-Cash Tender Offer of €11.00 per Share to Shareholders of Kloeckner & Co SE

Les Echos

Published on 02/05/2026 at 11:30, 2 hours 34 minutes ago

Déclaration nombre d'actions et droits de vote - 05.02.2026
Published on 02/05/2026 at 11:30, 2 hours 34 minutes ago

Disclosure of shares outstanding and voting rights - 05.02.2026
Published on 02/04/2026 at 18:04, 19 hours 59 minutes ago

Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 19 hours 59 minutes ago

Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 20 hours 19 minutes ago

Information concerning the total number of voting rights and shares 2026 01 31

View all LES ECHOS COMFI WIRE